MDM2 and chronic myelogenous leukemia, BCR-ABL1 positive: In addition they demonstrated that activation of p53 via MDM2 inhibition triggers apoptosis in blast cells, as well as in proliferating and quiescent CD34+ cells obtained from patients with BC-CML [40].